Omnidirectional vision systems calibration, feature extraction and 3D information /

Por Puig, Luis., Guerrero, J J.
Publicado em 2013

Educational algebra a theoretical and empirical approach /

Por Filloy, Eugenio, Rojano, Teresa, Puig, Luis
Publicado em 2008

Omnidirectional Structured Light in a Flexible Configuration

Por Paniagua, Carmen, Puig, Luis, Guerrero, José J.
Publicado em 2013

Predictors of biologic treatment of psoriasis: a non-interventional study

Por Puig, Luis, Fan, Tao, Ding, Qian, Smith, Nancy E
Publicado em 2014

Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

Por Adsit, Sandra, Zaldivar, Enrique Rivas, Sofen, Howard, Dei-Cas, Ignacio, Maldonado-García, César, Peñaranda, Elkin O., Puig, Luís, Meng, Xiangyi, Fox, Todd, Guana, Adriana
Publicado no Adv Ther (2017)

Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials

Por Adsit, Sandra, Zaldivar, Enrique Rivas, Sofen, Howard, Dei-Cas, Ignacio, Maldonado-García, César, Peñaranda, Elkin O., Puig, Luís, Meng, Xiangyi, Fox, Todd, Guana, Adriana
Publicado no Adv Ther (2017)

Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNC...

Por Blauvelt, Andrew, Papp, Kim A., Griffiths, Christopher E. M., Puig, Luis, Weisman, Jamie, Dutronc, Yves, Kerr, Lisa Farmer, Ilo, Dapo, Mallbris, Lotus, Augustin, Matthias
Publicado no Am J Clin Dermatol (2017)

Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque...

Por Blauvelt, Andrew, Papp, Kim A., Griffiths, Christopher E. M., Puig, Luis, Weisman, Jamie, Dutronc, Yves, Kerr, Lisa Farmer, Ilo, Dapo, Mallbris, Lotus, Augustin, Matthias
Publicado no Am J Clin Dermatol (2018)

Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent

Por Kristensen, Lars Erik, Alten, Rieke, Puig, Luis, Philipp, Sandra, Kvien, Tore K., Mangues, Maria Antonia, van den Hoogen, Frank, Pavelka, Karel, Vulto, Arnold G.
Publicado no BioDrugs (2018)

The Role of Invasive Therapies in Elderly Patients with Acute Myocardial Infarction

Por Nicolau, José C., Lemos, Pedro A., Wajngarten, Maurício, Giraldez, Roberto R., Serrano, Carlos V., Martinez, Eulógio E., Baracioli, Luciano M., Kalil, Roberto, Jatene, Fábio B., Dallan, Luis A., Puig, Luis B., Stolf, Noedir A.
Publicado em 2009

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants

Por Luger, Thomas, Boguniewicz, Mark, Carr, Warner, Cork, Michael, Deleuran, Mette, Eichenfield, Lawrence, Eigenmann, Philippe, Fölster-Holst, Regina, Gelmetti, Carlo, Gollnick, Harald, Hamelmann, Eckard, Hebert, Adelaide A, Muraro, Antonella, Oranje, Arnold P, Paller, Amy S, Paul, Carle, Puig, Luis, Ring, Johannes, Siegfried, Elaine, Spergel, Jonathan M, Stingl, Georg, Taieb, Alain, Torrelo, Antonio, Werfel, Thomas, Wahn, Ulrich
Publicado no Pediatr Allergy Immunol (2015)